Visit adherence and visual acuity outcomes in patients with diabetic macular edema: a secondary analysis of DRCRnet Protocol T

[1] Ciulla TA(2018)Real-world outcomes of anti-vascular endothelial growth factor therapy in diabetic macular edema in the United States Ophthalmol Retina 2 1179-1187

[2] Bracha P(2016)Trends in the care of diabetic macular edema: analysis of a national cohort PloS One 11 e0149450-1621

[3] Pollack J(2014)Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema Clin Ophthalmol 8 1611-91

[4] Williams DF(2018)Vision outcomes following anti-vascular endothelial growth factor treatment of diabetic macular edema in clinical practice Am J Ophthalmol 191 83-S60

[5] VanderBeek BL(2001)Treatment adherence in chronic disease J Clin Epidemiol 54 S57-242

[6] Shah N(2020)Association of visit adherence and visual acuity in patients with neovascular age-related macular degeneration JAMA Ophthalmol 138 237-2460

[7] Parikh PC(2014)Gaps in receipt of regular eye examinations among Medicare beneficiaries diagnosed with diabetes or chronic eye diseases Ophthalmology 121 2452-785

[8] Ma L(1991)Early photocoagulation for diabetic retinopathy. ETDRS report number 9 Ophthalmology 98 766-236

[9] Kiss S(2019)Loss to follow up after anti-vascular endothelial growth factor injections in patients with diabetic macular edema Ophthalmol Retina 3 230-20

[10] Liu Y(2018)Association of treatment adherence with real-life VA outcomes in AMD, DME, and BRVO patients Clin Ophthalmol 12 13-1392

[1] Ciulla TA(2018)Real-world outcomes of anti-vascular endothelial growth factor therapy in diabetic macular edema in the United States Ophthalmol Retina 2 1179-1187

[2] Bracha P(2016)Trends in the care of diabetic macular edema: analysis of a national cohort PloS One 11 e0149450-1621

[3] Pollack J(2014)Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema Clin Ophthalmol 8 1611-91

[4] Williams DF(2018)Vision outcomes following anti-vascular endothelial growth factor treatment of diabetic macular edema in clinical practice Am J Ophthalmol 191 83-S60

[5] VanderBeek BL(2001)Treatment adherence in chronic disease J Clin Epidemiol 54 S57-242

[6] Shah N(2020)Association of visit adherence and visual acuity in patients with neovascular age-related macular degeneration JAMA Ophthalmol 138 237-2460

[7] Parikh PC(2014)Gaps in receipt of regular eye examinations among Medicare beneficiaries diagnosed with diabetes or chronic eye diseases Ophthalmology 121 2452-785

[8] Ma L(1991)Early photocoagulation for diabetic retinopathy. ETDRS report number 9 Ophthalmology 98 766-236

[9] Kiss S(2019)Loss to follow up after anti-vascular endothelial growth factor injections in patients with diabetic macular edema Ophthalmol Retina 3 230-20

[10] Liu Y(2018)Association of treatment adherence with real-life VA outcomes in AMD, DME, and BRVO patients Clin Ophthalmol 12 13-1392